This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Semper Paratus Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Semper Paratus Acquisition Corporation(NasdaqGM:LGST) dropped from NASDAQ Composite Index CI
Tevogen Bio Inc completed the acquisition of Semper Paratus Acquisition Corporation from a group of shareholders in a reverse merger transaction. CI
Semper Paratus Acquisition Shareholders Approve Tevogen Bio Deal MT
Semper Paratus Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Semper Paratus Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Semper Paratus Acquisition to Merge With Tevogen Bio; to Bring Tevogen Public MT
Biotech firm Tevogen Bio enters $1.2 bln SPAC deal for US listing RE
Biotech firm Tevogen Bio to go public in $1.2 billion SPAC deal RE
Tevogen Bio Inc entered into a merger agreement to acquire Semper Paratus Acquisition Corporation for $1.5 billion in a reverse merger transaction. CI
Insider Sell: Semper Paratus Acquisition MT
Semper Paratus Acquisition Corporation Announces CEO Changes CI
Semper Paratus Acquisition Corporation Announces CFO Changes CI
Semper Paratus Acquisition Corporation Announces Board Changes CI
Semper Paratus Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Semper Paratus Acquisition Corporation announced that it expects to receive $8.988889 million in funding from Semper Paratus Sponsor LLC CI
Semper Paratus Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Semper Paratus Acquisition Corporation Auditor Raises 'Going Concern' Doubt CI
Semper Paratus Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Semper Paratus Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Semper Paratus Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Certain Class B Ordinary Shares of Semper Paratus Acquisition Corporation are subject to a Lock-Up Agreement Ending on 3-MAY-2022. CI
Semper Paratus Acquisition Corporation Announces Chief Financial Officer Changes CI
Semper Paratus Acquisition Corporation Announces Executive Changes CI
Semper Paratus Acquisition Corporation Reports Earnings Results for the Eight Months Ended December 31, 2021 CI
Chart SEMR PARA
More charts
Semper Paratus Acquisition Corporation (Semper Paratus) is a blank check company. The Company is formed for the purpose of entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. It intends to concentrate its efforts to pursue an acquisition opportunity in the transportation, supply chain and logistics industry. The Company has not commenced any operations nor generated any revenues.
Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. LGST Stock
  4. News SEMR PARA
  5. Semper Paratus Acquisition to Merge With Tevogen Bio; to Bring Tevogen Public
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW